WallStreetZenWallStreetZen

NASDAQ: NXL
Nexalin Technology Inc Earnings & Revenue

NXL past revenue growth

How has NXL's revenue growth performed historically?
Company
-90.16%
Industry
9.1%
Market
17.86%
NXL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NXL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

NXL earnings and revenue history

Current Revenue
$128.6k
Current Earnings
-$4.6M
Current Profit Margin
-3,574.2%

NXL Return on Equity

Current Company
-105.4%
Current Industry
8%
Current Market
-9.4%
NXL's Return on Equity (-105.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when NXL announces earnings.

NXL Return on Assets

Current Company
-80.1%
Current Industry
4.6%
NXL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NXL Return on Capital Employed

Current Company
-141.02%
Current Industry
7.2%

NXL vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NXL$128.64k-$4.56M-$4.60M-90.16%N/A
AFIB$19.66M-$21.40M-$32.79M+125.93%N/A
VVOS$14.50M-$15.16M-$15.41M+50.88%N/A
BIOL$49.16M-$15.44M-$37.62M+1.27%N/A
BSGM$141.00k-$29.25M-$30.04M-42.94%N/A

Nexalin Technology Earnings & Revenue FAQ

What were NXL's earnings last quarter?

Nexalin Technology (NASDAQ: NXL) reported Q3 2023 earnings per share (EPS) of -$0.31, up 933.33% year over year. Total Nexalin Technology earnings for the quarter were -$2.30 million. In the same quarter last year, Nexalin Technology's earnings per share (EPS) was -$0.03.

If you're new to stock investing, here's how to buy Nexalin Technology stock.

What was NXL's earnings growth in the past year?

As of Q1 2024, Nexalin Technology's earnings has grown year over year. Nexalin Technology's earnings in the past year totalled -$4.60 million.

What was NXL's revenue last quarter?

Nexalin Technology (NASDAQ: NXL) reported Q3 2023 revenue of $24.11 thousand up 95.58% year over year. In the same quarter last year, Nexalin Technology's revenue was $545.32 thousand.

What was NXL's revenue growth in the past year?

As of Q1 2024, Nexalin Technology's revenue has grown -90.16% year over year. This is 99.25 percentage points lower than the US Medical Devices industry revenue growth rate of 9.1%. Nexalin Technology's revenue in the past year totalled $128.64 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.